SEC Company Response from PRECISION BIOSCIENCES INC (DTIL) (CIK 0001357874) (DTIL) — Mar 25, 2019
PRECISION BIOSCIENCES INC (DTIL) (CIK 0001357874)
Date: March 25, 2019 · CIK: 0001357874 · Accession: 0001193125-19-085252
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-230034
Letter
Re: Precision BioSciences, Inc.
March 25, 2019
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Jeffrey Gabor
Registration Statement on Form S-1
File No. 333-230034
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between March 18, 2019 and the date hereof, approximately 1,907 copies of the Preliminary Prospectus dated March 18, 2019 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement.
We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on March 27, 2019 or as soon thereafter as practicable.
[Signature page follows]
Very truly yours,
J.P. Morgan Securities LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP March 25, 2019 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Jeffrey Gabor Re: Precision BioSciences, Inc. Registration Statement on Form S-1 File No. 333-230034 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between March 18, 2019 and the date hereof, approximately 1,907 copies of the Preliminary Prospectus dated March 18, 2019 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement. We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on March 27, 2019 or as soon thereafter as practicable. [Signature page follows] Very truly yours, J.P. Morgan Securities LLC Goldman Sachs & Co. LLC Jefferies LLC Barclays Capital Inc. As representatives of the Underwriters J.P. Morgan Securities LLC By: /s/ David Ke Name: David Ke Title: Executive Director Goldman Sachs & Co. LLC By: /s/ Lyla Bibi Name: Lyla Bibi Title: Managing Director Jefferies LLC By: /s/ Charlie Glazer Name: Charlie Glazer Title: Managing Director Barclays Capital Inc. By: /s/ Victoria Hale Name: Victoria Hale Title: Vice President [Signature Page to Underwriters Acceleration Letter]